Medication info

Smofkabiven Injection

Prescription medicationSolutionInjection
Ingredient · strength
L-Alanine›14gL-Arginine›12gGlycine›11gL-Histidine›3gL-Isoleucine›5gL-Leucine›7.4gL-Lysine Acetate›9.3gL-Methionine›4.3gL-Phenylalanine›5.1gL-Proline›11.2gL-Serine›6.5gTaurine›1gL-Threonine›4.4gL-Tryptophan›2gL-Tyrosine›0.4gL-Valine›6.2gCalcium Chloride Hydrate›0.74gAnhydrous Sodium Glycerophosphate›4.18gMagnesium Sulfate Heptahydrate›2.47gPotassium Chloride›4.48gSodium Acetate Hydrate›5.62gZinc Sulfate Heptahydrate›0.023gGlucose Monohydrate›462gSoybean Oil›60gTriglycerides Medium-Chain›60gPurified Olive Oil›50gPurified Fish Oil (High Dose Omega-3 Fatty Acids)›30g
Manufacturer / importer
Fresenius Kabi Korea Ltd.
Appearance
This product consists of a plastic container for infusion divided into three compartments, with an oxygen absorber placed in between them. Each inner bag contains an amino acid and electrolyte solution.
Packaging
986 mL/bag [(A solution 500 mL, B solution 298 mL, C solution 188 mL) x 4], 1477 mL/bag [(A solution 750 mL, B solution 446 mL, C solution 281 mL) x 4], 1970 mL/bag [(A solution 1000 mL, B solution 595 mL, C solution 375 mL) x 4]
Approval status
Active

MFDS item code 200811793 · Approved 2008.12.23 · Insurance code 650901580,650901590,650901600

Summary

Main use
Improvement of nutritional deficiencies through parenteral nutrition (calories, amino acids, etc.)
Who receives it
Adults · Children
Adult administration
The dose and infusion rate should be determined according to the patient's ability to eliminate fat and metabolize nitrogen and glucose, and nutritional requirements. The dose should be individualized, taking into account the patient's condition, body weight, nutritional and energy requirements, and any additional oral/enteral intake. Trace elements, vitamins, electrolytes, etc. may be added depending on the patient's condition. Nitrogen requirements to maintain body protein depend on the patient's condition (e.g., nutritional status and catabolic stress or anabolism). Children aged 12 years and older and adults - Patients with normal nutritional status or mild metabolic stress: 0.6-0.9 g/kg of amino acids per day (0.10-0.15 g/kg of nitrogen) - Patients with moderate to high metabolic stress, regardless of nutritional imbalance: 0.9-1.6 g/kg of amino acids per day (0.15-0.25 g/kg of nitrogen) In very special cases (e.g., burns or marked anabolism), the nitrogen amount may be higher. Dose A daily dose of 13-31 mL/kg of this medicine corresponds to 0.6-1.6 g/kg of amino acids (0.10-0.25 g/kg of nitrogen) and total energy of 14-35 kcal/kg (non-protein energy of 12-27 kcal/kg). This meets the requirements of most patients. For obese patients, the dose should be based on predicted normal body weight. Infusion rate The infusion rate should not exceed 2.0 mL/kg per hour (equivalent to 0.10 g/kg of amino acids, 0.25 g/kg of glucose, and 0.08 g/kg of fat). The recommended infusion duration is 14-24 hours. Maximum daily dose The maximum daily dose varies according to the patient's clinical condition and may change from day to day. The recommended maximum daily dose is 35mL/kg. The recommended maximum daily dose of 35 mL/kg provides 1.8 g/kg of amino acids (0.28 g/kg of nitrogen), 4.5 g/kg of glucose, 1.33 g/kg of fat, and total energy of 39 kcal/kg (equivalent to 31 kcal/kg of non-protein energy).
Child administration
Children aged 2-11 years: Pediatric patients show greater variability than adult patients; therefore, adjust the dose regularly according to requirements, up to 35 mL/kg per day of this medicine. Children aged 2-11 years: The infusion rate should not exceed 2.4 mL/kg per hour (equivalent to 0.12 g/kg of amino acids, 0.30 g/kg of glucose, and 0.09 g/kg of fat). Except in special circumstances, patients should be carefully monitored when receiving the recommended maximum infusion rate, and the infusion duration should not exceed 14 hours 30 minutes. The recommended infusion duration is 12-24 hours. Children aged 2-11 years: The maximum daily dose varies according to the patient's clinical condition and may change from day to day. The recommended maximum daily dose is 35mL/kg. The recommended maximum daily dose of 35 mL/kg provides 1.8 g/kg of amino acids (0.28 g/kg of nitrogen), 4.5 g/kg of glucose, 1.33 g/kg of fat, and total energy of 39 kcal/kg (equivalent to 31 kcal/kg of non-protein energy).

Ingredients

Importer
Fresenius Kabi Korea Ltd.

Efficacy & effects

Improvement of nutritional deficiencies through parenteral nutrition (calories, amino acids, etc.)

View approved original text

This medicine is used for children aged 2 years and older and adults who cannot obtain nutrition orally or through the gastrointestinal tract. It effectively improves the patient's nutritional status by supplying essential nutrients directly through venous infusion, including calories, amino acids, essential fatty acids, and omega-3 fatty acids. This helps support growth and recovery while preventing nutritional imbalances. It is mainly used when there is a need for long-term nutritional support.

How it is given

Adult administration

The dose and infusion rate should be determined according to the patient's ability to eliminate fat and metabolize nitrogen and glucose, and nutritional requirements. The dose should be individualized, taking into account the patient's condition, body weight, nutritional and energy requirements, and any additional oral/enteral intake. Trace elements, vitamins, electrolytes, etc. may be added depending on the patient's condition. Nitrogen requirements to maintain body protein depend on the patient's condition (e.g., nutritional status and catabolic stress or anabolism). Children aged 12 years and older and adults - Patients with normal nutritional status or mild metabolic stress: 0.6-0.9 g/kg of amino acids per day (0.10-0.15 g/kg of nitrogen) - Patients with moderate to high metabolic stress, regardless of nutritional imbalance: 0.9-1.6 g/kg of amino acids per day (0.15-0.25 g/kg of nitrogen) In very special cases (e.g., burns or marked anabolism), the nitrogen amount may be higher. Dose A daily dose of 13-31 mL/kg of this medicine corresponds to 0.6-1.6 g/kg of amino acids (0.10-0.25 g/kg of nitrogen) and total energy of 14-35 kcal/kg (non-protein energy of 12-27 kcal/kg). This meets the requirements of most patients. For obese patients, the dose should be based on predicted normal body weight. Infusion rate The infusion rate should not exceed 2.0 mL/kg per hour (equivalent to 0.10 g/kg of amino acids, 0.25 g/kg of glucose, and 0.08 g/kg of fat). The recommended infusion duration is 14-24 hours. Maximum daily dose The maximum daily dose varies according to the patient's clinical condition and may change from day to day. The recommended maximum daily dose is 35mL/kg. The recommended maximum daily dose of 35 mL/kg provides 1.8 g/kg of amino acids (0.28 g/kg of nitrogen), 4.5 g/kg of glucose, 1.33 g/kg of fat, and total energy of 39 kcal/kg (equivalent to 31 kcal/kg of non-protein energy).

Child administration

Children aged 2-11 years: Pediatric patients show greater variability than adult patients; therefore, adjust the dose regularly according to requirements, up to 35 mL/kg per day of this medicine. Children aged 2-11 years: The infusion rate should not exceed 2.4 mL/kg per hour (equivalent to 0.12 g/kg of amino acids, 0.30 g/kg of glucose, and 0.09 g/kg of fat). Except in special circumstances, patients should be carefully monitored when receiving the recommended maximum infusion rate, and the infusion duration should not exceed 14 hours 30 minutes. The recommended infusion duration is 12-24 hours. Children aged 2-11 years: The maximum daily dose varies according to the patient's clinical condition and may change from day to day. The recommended maximum daily dose is 35mL/kg. The recommended maximum daily dose of 35 mL/kg provides 1.8 g/kg of amino acids (0.28 g/kg of nitrogen), 4.5 g/kg of glucose, 1.33 g/kg of fat, and total energy of 39 kcal/kg (equivalent to 31 kcal/kg of non-protein energy).

Precautions

This medication must be used strictly according to a physician's instructions and if symptoms of anaphylaxis such as fever, chills, rash, or dyspnea occur during use, administration should be stopped immediately. When used with intravenous calcium preparations, precipitation may occur, so do not use the same infusion equipment simultaneously; the infusion line should be thoroughly cleaned if necessary. Particular caution is required when administering to premature or underweight infants, and there have been reports of fatalities in cases with severe respiratory diseases, so it should be administered carefully. It should not be administered to patients with allergies to fish, eggs, soybeans, or peanuts, as well as those with severe hyperlipidemia, liver dysfunction, bleeding disorders, renal failure, acute shock, uncontrolled hyperglycemia, etc. Patients with renal failure, diabetes, or liver dysfunction should be administered cautiously, and during administration, blood triglyceride levels, electrolytes, blood glucose, and liver function should be periodically monitored to detect abnormalities at an early stage. This medication may cause side effects such as fat overload syndrome, amino acid overload, and hyperglycemia in cases of overdose, so the administration rate and dosage must be strictly managed. Additionally, this product contains soybean oil, fish oil, and egg yolk phospholipids, which may rarely cause allergic reactions, so caution is needed for patients with a history of allergies. Aseptic procedures are essential during administration to prevent infections, and before administration, the solution should be checked for homogeneity and transparency. Safety during pregnancy or breastfeeding has not been established, and it should only be administered if the benefits outweigh the risks. In cases of overdose, administration should be discontinued or the infusion rate slowed, and if necessary, treatments such as insulin administration or hemodialysis may be required.

Side effects

  • Fever
  • chills
  • rash
  • shortness of breath
  • tachycardia
  • loss of appetite
  • nausea
  • vomiting
  • increased plasma enzyme levels
  • thrombophlebitis
Show 113 more
  • hypotension
  • hypertension
  • slight increase in body temperature
  • headache
  • dizziness
  • anaphylactic or anaphylactoid reactions
  • skin rash
  • hives
  • flushing
  • warmth
  • cold sensation
  • cyanosis
  • pallor
  • pain (neck, back, bones, chest, waist)
  • hyperlipidemia
  • fever
  • fatty infiltration
  • jaundice
  • hepatomegaly
  • splenomegaly
  • anemia
  • leukopenia
  • thrombocytopenia
  • coagulopathy
  • hemolysis
  • reticulocytosis
  • abnormal liver function test values
  • coma
  • nausea
  • sweating
  • elevated body temperature
  • hyperglycemia
  • allergic reactions
  • constipation
  • diarrhea
  • pneumonia
  • stomatitis
  • delirium
  • dyspepsia
  • abdominal pain
  • hypoalbuminemia
  • insomnia
  • febrile neutropenia
  • generalized weakness
  • edema
  • urinary disorders
  • hematuria
  • weight loss
  • hypoglycemia
  • hypocalcemia
  • heartburn
  • aspiration pneumonia
  • hematemesis
  • runny nose
  • extravasation at the injection site
  • phlebitis
  • procedure site reaction
  • dysuria
  • cough
  • infection
  • thromboembolism
  • melena
  • vasculitis
  • skin infection
  • pulmonary edema
  • sepsis
  • Clostridium infection
  • candidiasis
  • dental disease
  • pancreatitis
  • weight gain
  • fluid overload
  • spinal cord compression
  • vaginal bleeding
  • tissue fluid retention
  • hyponatremia
  • intestinal obstruction
  • cervical cancer
  • gum bleeding
  • pharyngeal disease
  • depression
  • pressure ulcers
  • urinary incontinence
  • urinary tract infection
  • malnutrition
  • laceration
  • gastroesophageal reflux
  • aspergillosis
  • oral thrush
  • neuropathic pain
  • neuropathy
  • esophagitis
  • vesicles
  • wound infection
  • epigastric pain
  • frequent urination
  • anxiety
  • ascites
  • abdominal discomfort
  • atelectasis
  • peripheral neuropathy
  • hiccups
  • colitis
  • leg edema
  • cerebral ischemia
  • acute renal failure
  • myalgia
  • hypersensitivity
  • exacerbation of hypertension
  • conjunctival hemorrhage
  • hemoptysis
  • sputum disease
  • voice disorders

Not everyone experiences these, and they can vary from person to person.

Storage

This product should be stored in a sealed container and kept in a cool place, below 25 degrees Celsius. It is important not to freeze it, as freezing may alter the product's components.

Appearance and packaging

Appearance

This product consists of a plastic container for infusion divided into three compartments, with an oxygen absorber placed in between them. Each inner bag contains an amino acid and electrolyte solution.

Package unit

986 mL/bag [(A solution 500 mL, B solution 298 mL, C solution 188 mL) x 4], 1477 mL/bag [(A solution 750 mL, B solution 446 mL, C solution 281 mL) x 4], 1970 mL/bag [(A solution 1000 mL, B solution 595 mL, C solution 375 mL) x 4]

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.